China
Africa
Explore chapters and articles related to this topic
Assessment of Co-occurring Disorders, Levels of Care, and ASAM Requirements
Published in Tricia L. Chandler, Fredrick Dombrowski, Tara G. Matthews, Co-occurring Mental Illness and Substance Use Disorders, 2022
Elizabeth Reyes-Fournier, Tara G. Matthews, Tom Alexander
Eating Disorder Diagnostic Scale (EDDS): The EDDS is a scale designed to be used on clients from ages 13 to 65 to screen and diagnose eating disorders after treatment. It is a 22-item self-report (Stice et al., 2000).
Assessment of eating disorders
Published in Stephen Wonderlich, James E Mitchell, Martina de Zwaan, Howard Steiger, Eric F van Furth, Annual Review of Eating Disorders Part 1 – 2007, 2018
Marion P Olmsted, Traci McFarlane, Jacqueline Carter, Kathryn Trottier
The EDDS is a 22-item self-report scale designed to provide DSM-IV diagnoses of AN, BN, and BED (Stice et al.2000). Encouraging evidence of reliability and validity was provided in the original report and a significant body of additional evidence was recently published. Stice and colleagues (2004) conducted four separate psychometric studies of the EDDS. In the first, based on a sample of 728 nonclinical girls and women, the EDDS had high internal consistency, good convergent validity (as indicated by correlations with other measures), and excellent criterion validity (demonstrated by very high concordance with diagnoses based on the EDE interview administered to a subsample of participants). The second study provided preliminary evidence that the EDDS was sensitive to change following a prevention intervention offered to university women, and the third study was a larger intervention study which compared the EDDS to the EDE in terms of sensitivity to change. The EDDS composite score was sensitive to change but the EDDS diagnoses were not as sensitive to change as those based on the EDE. In the fourth study the EDDS demonstrated predictive validity in a sample of 220 adolescent girls by predicting new onset of binge eating, compensatory behaviours, and depression at one year follow-up. There is now significant evidence that the EDDS may be valid and useful in studies of etiology, prevention, and treatment.
Motivation to change predicts naturalistic changes in binge eating and purging, but not fasting or driven exercise among individuals with eating disorders
Published in Eating Disorders, 2022
P. Evelyna Kambanis, Angeline R. Bottera, Christopher J. Mancuso, Kyle P. De Young
The EDDS (Stice et al., 2000) is a 22-item self-report measure assessing ED attitudes and behaviors over the previous three months to derive 4th edition Diagnostic and Statistical Manual of Mental Disorder (DSM-IV; American Psychiatric Association [APA], 1994) ED diagnoses. The EDDS is highly specific and sensitive for this purpose (e.g., Anderson et al., 2009; Krabbenborg et al., 2012). A masters-level graduate student used the EDDS to determine eligibility based on a diagnostic scheme (Table 1) that approximated DSM-5 (APA, 2013) ED diagnoses via telephone and was able to clarify responses to items where ambiguity existed. We used items 3 and 4 (i.e., Has your weight/shaped influenced how you think about (judge) yourself as a person?) to determine eligibility on over-evaluation of shape and weight, and we added two items to ascertain magnitude of distress about BE and/or purging. These items followed the EDDS’s 7-point scale; scores of 4 (moderately) or higher met the inclusion criterion for that item. The symptom composite scale demonstrated good internal consistency (α = .85).
Factors determining the treatment ineffectiveness in multiple sclerosis
Published in Neurological Research, 2022
After at least 6 months of correct DMT use in the 3rd and 6th months, the presence of ≤2 MR lesions and ≥0.5 points or <2 points increase in EDSS in patients with EDSS ≤5.5 are defined as treatment failure. Rio et al. showed that disease progression and persistent MR activity in patients receiving INF therapy significantly increased the likelihood of relapse and disease progression at a follow-up of 12 to 36 months [1]. In addition, a confirmed increase in EDSS score ≥2 in patients with EDSS ≤5.5 or an increase of ≥0.5 points in patients with EDSS ≥5.5 at the 3rd and 6th months of treatment is also defined as treatment failure. The combination of progression in EDDS with MRI activity and relapse more clearly reveals treatment failure. The increase in EDSS score ≥2 is significant in patients with EDSS ≤5.5, while smaller EDSS changes are significant in patients with greater disability (EDSS ≥5.5). Treatment failure is also defined as an attack at 3rd or 6th months of initiation and an increase in EDSS score ≥0.5 points, and a confirmed increase of <2 points in patients with EDSS ≤5.5 after at least 6 months of correct DMT use. Continuation of combined activity (relapses and EDSS progression) after the initiation of treatment indicates that the immune-mediated phenomenon cannot be controlled. Interestingly, the inflammatory activity continues following the initiation of treatment when the initial treatment is ineffective.
Cognitive dissonance-based eating disorder prevention: pilot study of a cultural adaptation for the Orthodox Jewish community
Published in Eating Disorders, 2021
Arielle F. Casasnovas, Kathryn M. Huryk, Devorah Levinson, Sara Markowitz, Shoshana Friedman, Eric Stice, Katharine L. Loeb
The Eating Disorder Diagnostic Scale (EDDS; Stice, Fisher, & Martinez, 2004) is a 20-item measure developed to assess eating disorder symptoms. Responses can be used to generate DSM-IV diagnoses for anorexia nervosa, bulimia nervosa, and binge eating disorder. Responses can also be summed to control for different response formats to create an overall eating disorder symptom composite. The current study used the overall eating disorder symptom composite.1 The EDDS has been shown to be internally consistent (α = .89) and valid in prior studies of young women (Stice et al., 2004). Cronbach’s alpha was .82 at baseline, .79 at post-intervention, and .76 at follow-up.